We're Keeping An Eye On Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate

Yahoo FinanceJul 12 10:15 ET

Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders

Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research a

newsfileJun 27 12:29 ET

Cardiol Therapeutics Initiated at Buy by Roth MKM

Cardiol Therapeutics Initiated at Buy by Roth MKM

Dow JonesJun 26 08:56 ET

Roth MKM Initiates Cardiol Therapeutics(CRDL.US) With Buy Rating, Announces Target Price $10

Roth MKM analyst Jason Wittes initiates coverage on $Cardiol Therapeutics(CRDL.US)$ with a buy rating, and sets the target price at $10.According to TipRanks data, the analyst has a success rate of 50

Moomoo NewsJun 26 05:31 ET · Ratings

Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 P.m. EDT

Toronto, Ontario--(Newsfile Corp. - June 25, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research a

newsfileJun 25 07:27 ET

CCORF Maintains Cardiol Therapeutics(CRDL.US) With Buy Rating, Maintains Target Price $8

CCORF analyst Edward Nash maintains $Cardiol Therapeutics(CRDL.US)$ with a buy rating, and maintains the target price at $8.According to TipRanks data, the analyst has a success rate of 38.1% and a to

Moomoo NewsJun 24 07:31 ET · Ratings